NEFA-glucose comodulation model of β-cell insulin secretion in 24-h multiple-meal test

American Journal of Physiology - Endocrinology and Metabolism

Volumn 292, Issue 6, 2007, Pages

  Salinari, Serenella ^a,e   Bertuzzi, Alessandro ^b   Manco, Melania ^c   Mingrone, Geltrude ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

^c Liver Unit

^d CATHOLIC UNIVERSITY   (Italy)

^e Dipartimento di Informatica e Sistemistica   (Italy)

Author keywords

Mathematical model; Nonesterified fatty acid

Indexed keywords

C PEPTIDE; FATTY ACID; GLUCOSE;

ARTICLE; BLOOD SAMPLING; CALORIMETRY; CENTRAL VENOUS CATHETER; CLAMP; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MATHEMATICAL MODEL; OBESITY; PRIORITY JOURNAL;

BLOOD GLUCOSE; C-PEPTIDE; CIRCADIAN RHYTHM; EATING; FATTY ACIDS, NONESTERIFIED; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; MODELS, BIOLOGICAL; OBESITY, MORBID; OSMOLAR CONCENTRATION; WEIGHT LOSS;

EID: 34447572781     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00563.2006     Document Type: Article

References (33)

1. Boucher A, Lu D, Burgess SC, Telemaque-Potts S, Jensen MV, Mulder H, Wang MY, Unger RH, Sherry AD, Newgard CB. Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue. J Biol Chem 279: 27263-27271, 2004.
2. Brun T, Assimacopoulos-Jeannet F, Corkey BE, Prentki M. Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1. Diabetes 46: 393-400, 1997.
3. Campioni M, Toffolo GM, Shuster LT, Service FJ, Rizza RA, Cobelli C. Incretin effect potentiates β-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study. Am J Physiol Endocrinol Metab 292: E54-E60, 2007.
4. Caumo A, Luzi L. First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab 287: E371-E385, 2004.
5. Culebras JM, Moore FD. Total body water and the exchangeable hydrogen. I. Theoretical calculation of nonaqueous exchangeable hydrogen in man. Am J Physiol Regul Integr Comp Physiol 232: R54-R59, 1977.
6. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E214-E223, 1979.
7. Dobbins RL, Chester MW, Daniels MB, McGarry JD, Stein DT. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes 48: 1613-1618, 1998.
8. Gremlich S, Bonny C, Waeber G, Thorens B. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J Biol Chem 272: 30261-30269, 1997.
9. Grundy S. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Pressure in Adults (Adult Treatment Panel III). Circulation 106: 3145-3421, 2002.
10. Herrero L, Rubǐ B, Sebastiàn D, Serra D, Asins G, Maechler P, Prentki M, Hegardt FG. Alteration of the malonyl-CoA/carnitine palmitoyltransferase I interaction in the β-cell impairs glucose-induced insulin secretion. Diabetes 54: 462-471, 2005.
11. Kelley DE, Goodpaster BH, Storlien L. Muscle triglyceride and insulin resistance. Annu Rev Nutr 22: 325-346, 2002.
12. Lameloise N, Muzzin P, Prentki M, Assimacopoulos-Jeannet F. Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion? Diabetes 50: 803-809, 2001.
13. Landaw EM, DiStefano 3rd JJ. Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations. Am J Physiol Regul Integr Comp Physiol 246: R665-R677, 1984.
14. Manco M, Bertuzzi A, Salinari S, Scarfone A, Calvani M, Greco AV, Mingrone G. The ingestion of saturated fatty acid triacylglycerols acutely affects insulin secretion and insulin sensitivity in human subjects. Br J Nutr 92: 895-903, 2004.
15. Mari A, Camastra S, Toschi E, Giancaterini A, Gastaldelli A, Mingrone G, Ferrannini E. A model for glucose control of insulin secretion in 24 h of free living. Diabetes 50, Suppl 1: S164-S168, 2001.
16. Mari A, Schimtz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E. Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283: E1159-E1166, 2002.
17. Muscelli E, Mari A, Natali A, Astiarraga BD, Camastra S, Frascerra SD, Holst JJ, Ferrannini E. Impact of incretin hormones on β-cell function in subjects with normal or impaired glucose tolerance. Am J Physiol Endocrinol Metab 291: E1144-E1150, 2006.
18. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Frank B. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and in type I diabetic patients. J Clin Invest 77: 98-105, 1986.
19. Prentky M, Corkey BE. Are the beta-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45: 273-283, 1996.
20. Roduit R, Nolan C, Alarcon C, Moore P, Barbeau A, Delghingaro-Augusto V, Przybykowsky E, Morin J, Massé F, Massie B, Ruderman N, Rhodes C, Poitout V, Prentki M. A role for the malonyl-CoA/longchain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli. Diabetes 53: 1007-1019, 2004.
21. Shao J, Thu D. The Jackknife and Bootstrap. New York: Springer Verlag, 1995.
22. Sheng HP, Huggins RA. A review of body composition studies with emphasis on total body water and fat. Am J Clin Nutr 32: 630-647, 1979.
23. Siri WE. Body composition from fluid spaces and density: analysis of methods. In: Techniques of Measuring Body Composition, edited by Brozek J and Henschel A. Washington, DC: National Academy of Sciences, National Research Council, 1961, p. 107-141.
24. Stein DT, Esser V, Stevenson B, Lane KE, Whiteside JH, Daniels MB, Chen S, McGarry JD. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97: 2728-2735, 1996.
25. Stein DT, Stevenson B, Chester MW, Basit M, Daniels MB, Turley SD, McGarry JD. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100: 398-403, 1997.
26. Toffolo G, Breda E, Cavaghan MK, Ehrmann DA, Polonsky KS, Cobelli C. Quantitative indexes of β-cell function during graded up&down glucose infusion from C-peptide minimal models. Am J Physiol Endocrinol Metab 280: E2-E10, 2001.
27. Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41: 368-377, 1992.
28. Vella A, Rizza RA. Extrapancreatic effects of GIP and GLP-1. Horm Metab Res 36: 830-836, 2004.
29. Wajda S, Godfrey KR, Rubitz H. Similarity transformation approach to identifiability analysis of non linear compartmental models. Math Biosci 93: 217-248, 1989.
30. World Health Organization. Globalization Diet and Non Communicable Diseases. Geneva, Switzerland: World Health Organization, 2002.
31. Yaney GC, Korchak HM, Corkey BE. Long-chain acyl CoA regulation of protein kinase C and fatty acid potentiation of glucose-stimulated insulin secretion in clonal beta-cells. Endocrinology 141: 1989-1998, 2000.
32. Yaney GC, Corkey BE. Fatty acid metabolism and insulin secretion in pancreatic beta cells. Diabetologia 46: 1297-1312, 2003.
33. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB, Zheng XX, Wheeler MB, Shulman GI, Chan CB, Lowell BB. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β-cell dysfunction, and type 2 diabetes. Cell 105: 745-755, 2001.